Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Crescent Biopharma (CBIO) Non Operating Income (2016 - 2025)

Crescent Biopharma (CBIO) has disclosed Non Operating Income for 7 consecutive years, with -$285000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income changed N/A to -$285000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $233000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at -$690000.0 for FY2025, 131.94% down from the prior year.
  • Non Operating Income for Q4 2025 was -$285000.0 at Crescent Biopharma, down from $1.3 million in the prior quarter.
  • The five-year high for Non Operating Income was $1.3 million in Q3 2025, with the low at -$760000.0 in Q2 2025.